S-Amlodipine (Levamlodipine)Third Party Manufacturing in India

S-Amlodipine, also known as Levamlodipine, is the pharmacologically active S-enantiomer of amlodipine. It works by selectively blocking the transmembrane influx of calcium ions through L-type calcium channels in vascular smooth muscle and cardiac tissue. This calcium channel blockade is stereospecific — only the S-enantiomer binds to and inhibits L-type calcium channels, while the R-enantiomer is essentially inactive at these receptors. By preventing calcium entry into smooth muscle cells, S-Amlodipine causes relaxation of arterial smooth muscle, leading to peripheral vasodilation and a reduction in peripheral vascular resistance. This results in a significant decrease in blood pressure. The antianginal effects are mediated through two mechanisms: first, dilation of peripheral arterioles reduces the workload on the heart by decreasing total peripheral resistance, which lowers myocardial oxygen demand; second, dilation of coronary arteries and arterioles increases myocardial oxygen supply. Unlike some other calcium channel blockers, S-Amlodipine has a gradual onset of action and a long elimination half-life of approximately 30 to 50 hours, which allows for once-daily dosing. It is well-tolerated in hypertensive patients and provides consistent blood pressure control over 24 hours.

Therapeutic Uses

S-Amlodipine is prescribed for the treatment of:

• Hypertension: S-Amlodipine is indicated for the management of essential hypertension in adults. By lowering peripheral vascular resistance through arterial vasodilation, it effectively reduces systolic and diastolic blood pressure. It can be used as monotherapy or in combination with other antihypertensive agents such as ACE inhibitors, angiotensin II receptor blockers, or thiazide diuretics.

• Stable Angina Pectoris: S-Amlodipine is indicated for the treatment of chronic stable angina. It improves exercise tolerance and reduces the frequency of anginal attacks through its coronary vasodilatory effects and reduction in myocardial oxygen demand.

• Vasospastic Angina (Prinzmetal's Angina): It is effective in managing vasospastic angina due to its ability to dilate coronary arteries and prevent coronary artery spasm.

Why Manufacturers Choose S-Amlodipine

S-Amlodipine is a high-demand molecule in the Indian pharmaceutical manufacturing sector because it offers the same therapeutic efficacy as racemic amlodipine at half the dose, reducing the pill burden for patients. As a chirally pure molecule, it appeals to formulation companies looking to differentiate their product portfolio with enantiomer-pure APIs. Indian manufacturers produce S-Amlodipine for both the domestic PCD franchise market and for export to regulated markets across Asia, Africa, and Latin America. The molecule is available in multiple tablet strengths, making it a versatile addition to any cardiovascular product line. Consistent demand from franchise partners and export-oriented companies makes S-Amlodipine one of the most sought-after molecules for third party manufacturing in India.